BETHESDA, Md., Dec. 17, 2012 /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX), an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced the pre-opening of a new clinic in Beijing's Central Business District ("CBD"), the sixth premium satellite clinic in the Beijing market affiliated with the United Family Healthcare ("UFH") network. On December 10, 2012, the Company held a pre-opening ceremony in conjunction with a forum on "International Healthcare in the Community," which was attended by government representatives from the Beijing Central Business District Administrative Committee and Beijing Chaoyang District Investment Promotion Bureau. General Practitioners and English-Mandarin bilingual nurses are now in place at the CBD clinic and are expected to begin seeing patients in January 2013. The new 300-plus square meter clinic offers a range of healthcare services, including Primary Care, Pediatrics, Gynecology, and Internal Medicine as well as support services including Ultrasound, Laboratory and Traditional Chinese Medicine. In addition, as part of the UFH network, the CBD clinic will offer patient referrals to specialists in the UFH system and convenient direct billing options with well-established international insurance companies. Roberta Lipson, President and CEO of Chindex, said, "The opening of the CBD clinic is another milestone in our progress at increasing the availability of quality healthcare to more people in our anchor markets. The establishment of a state-of-the-art clinic in our largest metropolitan market further enhances our competitive positioning in Beijing. It also bolsters our Beijing market presence to showcase what the company is capable of eventually rolling out to other target markets throughout China." About United Family Healthcare (UFH) United Family Healthcare (UFH) is the healthcare services division of Nasdaq-listed Chindex International Inc. (Nasdaq: CHDX). After 15 years in China, UFH has established itself in Beijing, Shanghai, Tianjin, Guangzhou and Wuxi as the provider of choice for those in China who want the very best in personalized healthcare. UFH constantly strives for quality, safety and service excellence. For more information about UFH, please visit www.ufh.com.cn. About Chindex International, Inc. Chindex is an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare currently operates in Beijing, Shanghai, Tianjin, Guangzhou and Wuxi. The Company also provides medical capital equipment and products through Chindex Medical Ltd., a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. With thirty years of experience, the Company's strategy is to continue its growth as a leading integrated healthcare provider in the Greater China region. Further company information may be found at the Company's website at http://www.chindex.com. Safe Harbor Statement Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the twelve months ended December 31, 2011, updates and additions to those "Risk Factors" in the Company's interim reports on Form 10-Q, Forms 8-K and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue" or similar terms or the negative of these terms. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. The Company has no obligation to update these forward-looking statements. Contact: ICR, Inc. Robert Koepp(+86) 10-6583-7516(646) 328-2510 SOURCE Chindex International, Inc.
Chindex (CHDX) spiked to a five-year high of $19.71 on Tuesday after the announcement that TPG and Shanghai Fosun Pharmaceutical would acquire the drug manufacturer. The deal is worth $369 million, and the consortium will pay $19.50 per share in cash for Chindex. Founder and Chief Executive Officer Roberta Lipson will stay on as CEO after the deal. The deal should give TPG and Fosun a foothold in China's private healthcare sector, which has been growing quickly as the Chinese government invests in it to alleviate pressure on public hospitals and to drive down prices through more competition in the market.
Shares of Chindex International (Nasdaq:CHDX) have taken a tremendous swing upward. The stock is trading at $10.09 as of 10:51 a.m. ET, 20.1% above Monday's closing price of $8.40. Volume is at 51,498, 0.9 times the daily average of 56,300.